Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating)’s stock price hit a new 52-week low on Tuesday . The stock traded as low as $23.43 and last traded at $23.45, with a volume of 38691 shares trading hands. The stock had previously closed at $24.14. Analyst Upgrades and Downgrades TARO has been the topic of […]
Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Saturday. Separately, HC Wainwright dropped their price target on shares of Taro Pharmaceutical Industries from $54.00 to $35.00 and set a “buy” rating on the stock in a research note […]
Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) had its price objective reduced by investment analysts at HC Wainwright from $73.00 to $54.00 in a report issued on Monday, MarketBeat Ratings reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 58.31% from the stock’s current […]
Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) issued its quarterly earnings results on Thursday. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.88 by ($0.15), MarketWatch Earnings reports. Taro Pharmaceutical Industries had a return on equity of 7.33% and a net margin of 0.19%. During the same quarter in the […]
Taro Pharmaceutical Industries Ltd.(NASDAQ:TARO): Concerns over aggressive interest rate hikes to fight the multi-decade high inflation and a looming recession have recently kept the stock market under pressure. However, growth stocks Taro Pharmaceutical (TARO), Superior Industries (SUP), Viavi Solutions (VIAV), CEVA (CEVA), and SMART Global Holdings (SGH) are well-positioned to rebound.